Resistance Exercise for Osteoporosis

Recruiting in Palo Alto (17 mi)

Overseen ByHARSHVARDHAN SINGH, PT,PHD

Age: 18+

Sex: Female

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Alabama at Birmingham

No Placebo Group

Trial Summary

What is the purpose of this trial?The aim of the 2 month randomized controlled trial is to investigate the feasibility of a novel progressive muscle resistance exercise in individuals with low bone mass.

Eligibility Criteria

This trial is for postmenopausal women who can walk on their own and have been diagnosed with low bone mass. It's not suitable for those with secondary osteoporosis, uncontrolled high blood pressure, current non-zoledronic acid osteoporosis treatments, liver or kidney disease, unmanaged thyroid issues, recent cancer history, previous year resistance training, inability to walk independently or a fragility fracture.

Inclusion Criteria

I have been diagnosed with low bone density.

I can walk by myself without help.

Exclusion Criteria

I have had cancer within the last 5 years.

My bone loss is due to an underlying health condition.

I have had a fracture from a minor injury.

I have liver or kidney disease.

I have taken medication for osteoporosis before.

I am currently being treated for osteoporosis, but not with zoledronic acid.

I cannot walk on my own.

My blood pressure is not controlled by medication.

My thyroid or parathyroid glands are not functioning properly.

Participant Groups

The study tests a new muscle-strengthening exercise program over six months to see if it's doable for women with weak bones after menopause. Participants are randomly chosen to either join the exercise group or be in a control group without this specific training.

2Treatment groups

Experimental Treatment

Active Control

Group I: Exercise trainingExperimental Treatment1 Intervention

The exercise training group will receive progressive muscle resistive exercise, 10 sets of exercises for 2 times per week for a total of 6 months.

Group II: ControlActive Control1 Intervention

The control group will be asked to maintain their normal lifestyle and will be advised to continue their standard care of treatment.